Digestive and Liver Disease Gastroenterology

An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn – ALICE (PRODIGE89 – UCGI44 – ALICE)

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →